Globhy
AllBusinessHealthMarketingTechnologyTravelUncategorized
Posted on 28 Oct 2026Edited on 28 Oct 2026

Share:

Radiation Oncology Market Size and Share Analysis: Opportunities for Cancer Care Equipment Manufacturers

Radiation Oncology Market Size and Share Analysis: Opportunities for Cancer Care Equipment Manufacturers

The global radiation oncology market size was valued at USD 11.42 billion in 2025 and is projected to grow from USD 12.78 billion in 2026 to USD 31.41 billion by 2034, registering a CAGR of 11.9% during the forecast period from 2026 to 2034. North America dominated the radiation oncology market with a market share of 39.2% in 2025.

The global radiation oncology market size was valued at USD 11.42 billion in 2025 and is projected to grow from USD 12.78 billion in 2026 to USD 31.41 billion by 2034, registering a CAGR of 11.9% during the forecast period from 2026 to 2034. North America dominated the radiation oncology market with a market share of 39.2% in 2025.

Radiation oncology is a medical specialty that uses radiation to treat cancer. It is an important part of cancer care and is often used alongside surgery, chemotherapy, and other treatments. Radiation therapy uses high-energy radiation to damage cancer cells and control their growth. In external beam radiation therapy, a machine directs radiation toward the targeted area of the body. Internal radiation therapy, including brachytherapy, places a radioactive source inside or near the tumor.

The radiation oncology market includes treatment machines, radiation delivery systems, treatment-planning technologies, and related equipment used by hospitals and specialized cancer centers. Advances in imaging, computer-based planning, and radiation delivery are helping healthcare professionals target tumors more accurately while limiting exposure to surrounding healthy tissues. As healthcare providers seek effective cancer treatment options, demand for modern radiation oncology technologies is expected to increase.

Market Drivers

Rising Adoption of Radiotherapy

The growing use of radiation therapy for different types of cancer is a major factor supporting market growth. Radiotherapy can be used as a primary treatment or combined with surgery and chemotherapy, depending on the cancer type, stage, and individual treatment plan. Improvements in radiation delivery also allow clinicians to direct radiation more precisely toward tumors.

Demand for radiotherapy equipment is particularly important in countries where cancer treatment infrastructure is expanding. Developing healthcare systems need additional treatment machines and facilities to improve access to cancer care. The Straits Research report highlights the need for additional radiotherapy machines in low- and middle-income countries, including China, India, and Brazil. These needs create opportunities for equipment manufacturers and technology providers.

Increasing Healthcare Expenditure

Higher healthcare spending can support investment in advanced cancer diagnosis and treatment. Hospitals and cancer centers may use additional funding to purchase modern radiation therapy systems, upgrade existing equipment, and improve treatment planning services. Public investment, private healthcare expansion, and cancer-care programs can also help increase access to radiotherapy.

As healthcare providers focus on treatment quality and clinical efficiency, demand may grow for systems that offer improved precision, better imaging guidance, and more efficient treatment workflows. However, the effect of increased spending depends on how funding is distributed and whether patients and healthcare facilities can afford the cost of treatment.

Market Restraints

Shortage of Skilled Radiotherapy Professionals

A shortage of trained professionals can limit the adoption of advanced radiation oncology systems. Radiotherapy requires coordinated work by radiation oncologists, medical physicists, radiographers, dosimetrists, nurses, and other healthcare specialists. These professionals help assess patients, plan radiation doses, operate equipment, and manage treatment-related side effects.

Advanced treatment systems require specialized training and technical knowledge. When facilities lack enough qualified staff, they may struggle to use their equipment efficiently, provide timely treatment, or expand services. Workload pressures and the retirement of experienced professionals can further increase staffing challenges. Investment in education, training, and workforce development is therefore important for supporting market growth.

Market Opportunities

Technological Advancements in Radiotherapy

Technological innovation is creating opportunities across the radiation oncology market. Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT), Volumetric-Modulated Arc Therapy (VMAT), stereotactic radiotherapy, and proton therapy are among the advanced approaches discussed in the market report.

These technologies can help clinicians plan and deliver radiation more accurately. Imaging guidance supports the localization of tumors, while advanced planning systems help determine how radiation should be distributed. Some techniques can deliver concentrated doses to specific targets while reducing unnecessary exposure to nearby tissues. Continued development of treatment-planning software, imaging systems, and adaptive treatment methods may improve clinical workflows and support demand for next-generation equipment.

Opportunities may also arise as healthcare systems develop new cancer centers and upgrade existing facilities. Manufacturers that provide reliable equipment, technical support, training, and workflow solutions may be better positioned to serve these expanding needs.

Radiation Oncology Market Segmentation

The market is segmented by therapy type, technology, application, end user, and region.

By Therapy Type

The market is divided into external beam radiation therapy and internal beam radiation therapy. External beam radiation therapy (EBRT) uses a machine outside the body to direct radiation toward a tumor. It includes linear accelerators and advanced systems such as stereotactic and proton-based technologies. The report identifies external beam radiation therapy as the dominant therapy-type segment.

Internal beam radiation therapy includes brachytherapy, in which a radioactive source is placed inside or near the treatment area. Brachytherapy is used for selected cancers and can offer targeted radiation delivery. The choice between external and internal radiation therapy depends on the cancer type, tumor location, and clinical requirements.

Share:

More in Health

View category
Can Uterine Fibroids Increase the Risk of Miscarriage?
Health
1

Can Uterine Fibroids Increase the Risk of Miscarriage?

The answer depends on several factors, including the size, number, and location of the fibroids. Some fibroids may interfere with embryo implantation, restrict the space available for a growing baby, or affect the uterine environment. Understanding the connection between fibroids and miscarriage can help you make informed decisions about your reproductive health and explore appropriate treatment options before or during pregnancy. How Do Fibroids Affect Pregnancy? Not all uterine fibroids affect pregnancy in the same way. Their location plays an important role in determining potential complications. - Submucosal fibroids: These develop inside the uterine cavity and may interfere with embryo implantation, increasing the risk of pregnancy complications. - Intramural fibroids: These grow within the muscular wall of the uterus. Larger fibroids that distort the uterine cavity may affect pregnancy development. - Subserosal fibroids: These grow on the outer surface of the uterus and are generally less likely to interfere with pregnancy. Fibroids that are large, multiple, or positioned near the uterine cavity may create challenges during pregnancy. Can Fibroids Cause Miscarriages? Yes, certain uterine fibroids can increase the risk of miscarriage, particularly when they affect the shape of the uterine cavity. These growths may interfere with the implantation of a fertilized egg or affect the blood supply needed to support early pregnancy. However, having fibroids does not automatically mean you will experience a miscarriage. Many women with uterine fibroids conceive naturally and carry healthy pregnancies to full term. The overall risk depends on individual circumstances, including fibroid location, size, and whether the growths distort the uterine cavity. If you have experienced repeated miscarriages, discussing fibroid evaluation with a healthcare provider can help identify possible contributing factors. Signs That Fibroids May Affect Your Pregnancy Some women experience no noticeable symptoms from uterine fibroids. Others may experience symptoms that require medical attention, including: - Pelvic pressure or persistent lower abdominal discomfort. - Heavy or prolonged menstrual bleeding before pregnancy. - Frequent urination due to pressure on the bladder. - Abdominal swelling or an enlarged uterus. - Pelvic pain during pregnancy. These symptoms do not necessarily indicate a miscarriage. However, severe abdominal pain, heavy bleeding, or unusual vaginal discharge during pregnancy should be evaluated promptly by a healthcare professional. How Are Fibroids Diagnosed During Pregnancy? Healthcare providers commonly use ultrasound examinations to identify uterine fibroids and monitor their size and location. An ultrasound can also help assess the pregnancy and check for potential complications. Your doctor may recommend additional monitoring depending on the number of fibroids, their position, and your pregnancy history. Regular prenatal appointments are important for tracking your baby's development and addressing any concerns early. Can Treating Fibroids Reduce the Risk of Miscarriage? Treatment depends on your symptoms, reproductive goals, and the characteristics of your fibroids. In some cases, doctors may recommend treating fibroids before pregnancy, particularly when they distort the uterine cavity or contribute to reproductive complications. Uterine Fibroid Embolization (UFE) is a minimally invasive treatment that reduces blood flow to fibroids, causing them to shrink over time. However, UFE is generally not recommended for women planning future pregnancies because its effects on fertility and pregnancy outcomes remain uncertain. Other treatment approaches may be more appropriate depending on individual circumstances. Protect Your Reproductive Health Understanding the relationship between fibroids and miscarriage can help you take informed steps toward a healthy pregnancy. Although certain fibroids may increase miscarriage risk, many women with these growths have successful pregnancies. If you have fibroids and are planning to conceive, consult a fibroid specialist to understand your treatment options. USA Fibroid Centers provides information about uterine fibroid conditions and minimally invasive treatment options to help women make informed decisions about their reproductive health.

READ ARTICLE
Carcinoid Syndrome Diarrhea Treatment Market Outlook: North America Leads the Global Market